Literature DB >> 9668241

Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome.

C M Harper1, A G Engel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668241     DOI： 10.1111/j.1749-6632.1998.tb10929.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Further observations in congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

2.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

3.  A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome.

Authors:  Amina Chaouch; Juliane S Müller; Velina Guergueltcheva; Marina Dusl; Ulrike Schara; Vidosava Rakocević-Stojanović; Christopher Lindberg; Rosana H Scola; Lineu C Werneck; Jaume Colomer; Andres Nascimento; Juan J Vilchez; Nuria Muelas; Zohar Argov; Angela Abicht; Hanns Lochmüller
Journal:  J Neurol       Date:  2011-08-07       Impact factor: 4.849

Review 4.  Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models.

Authors:  José David Otero-Cruz; Carlos Alberto Báez-Pagán; Luisamari Dorna-Pérez; Gary Emanuel Grajales-Reyes; Rosaura Teresa Ramírez-Ordoñez; Carlos A Luciano; Christopher Manuel Gómez; José Antonio Lasalde-Dominicci
Journal:  P R Health Sci J       Date:  2010-03       Impact factor: 0.705

5.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.